As the healthcare landscape continues to evolve, physical therapists find themselves at the forefront of integrating innovative treatments and medications into holistic patient care. This webinar delves into the transformative impact of glucagon-like peptide 1 receptor agonists (GLP-1 agonists) on managing obesity and diabetes, medications that 1 in 8 adults in the United States have taken. Originally utilized for diabetes management, GLP-1 agonists are now recognized as key players in the treatment of obesity, providing a new dimension to patient care that requires specific attention from physical therapy professionals.

In this presentation, attendees will gain insight into the prevalent use of GLP-1 agonists and the resultant physiological effects on patients. We will explore the role of physical therapists in aligning interventions with these medications to optimize patient outcomes. Participants will learn how to adapt their practice to accommodate the bodily changes and side effects associated with these drugs, ensuring that therapy sessions are both effective and patient-centered

The webinar will emphasize the role of collaboration with other healthcare professionals, such as dieticians, primary care physicians, and psychologists, to form a comprehensive care plan for patients undergoing GLP-1 agonist therapy. Attendees will learn strategies for motivating patients to maintain consistent physical activity and develop sustainable health behaviors, which are integral to the successful integration of medication and therapy.

Through this engaging session, physical therapists will be empowered to leverage their expertise in movement and behavior change principles, transforming society by optimizing movement to improve the human experience. By the end of the presentation, attendees will be equipped with the knowledge and tools to enhance their practice and support patients effectively in their health journeys, in accordance with the American Physical Therapy Association’s vision.

Join us to explore how these developments challenge conventional therapy practices and discover innovative approaches to promote optimal health through physical therapy.

Meet the Presenters

Todd Norwood, DPT, FACHE

Julie Mulcahy, DPT

Anna DeLaRosby, DPT

Learning Objectives:

• Understand the growing use and physiological effects of GLP-1 medications.
• Align physical therapy interventions with medication-related changes and side effects.
• Collaborate with dietitians, primary care providers, and psychologists for comprehensive care.
• Motivate patients to maintain physical activity and build sustainable health behaviors.
• Apply movement and behavior change principles to enhance patient outcomes in line with APTA’s vision.

CEUs:

CEUs are not being offered for this webinar.